Meningococcal polysaccharide vaccine group Y
- Generic Name
- Meningococcal polysaccharide vaccine group Y
- Brand Names
- Menquadfi, Menveo, Nimenrix
- Drug Type
- Biotech
- Unique Ingredient Identifier
- CBZ4BH7TJ1
- Background
Meningococcal group Y polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup Y. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup Y.
- Associated Conditions
- Invasive Meningococcal Infection caused by Neisseria meningitidis serogroup Y
Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants
- Conditions
- Meningococcal ImmunizationHealthy Volunteers
- Interventions
- Biological: Pentavalent Meningococcal ABCYW vaccineBiological: Pneumococcal 13-valent conjugate vaccine
- First Posted Date
- 2024-10-17
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Sanofi Pasteur, a Sanofi Company
- Target Recruit Count
- 750
- Registration Number
- NCT06647407
- Locations
- 🇩🇰
Investigational Site Number : 2080002, Hvidovre, Denmark
🇨🇿Investigational Site Number : 2030007, Plzeň, Czechia
🇨🇿Investigational Site Number : 2030004, Ostrava, Czechia
Study on Immunogenicity and Safety of a Meningococcal ACYW Conjugate Vaccine in Healthy Infants and Toddlers
- Conditions
- Meningococcal ImmunisationHealthy Volunteers
- Interventions
- First Posted Date
- 2024-02-29
- Last Posted Date
- 2025-03-07
- Lead Sponsor
- Sanofi Pasteur, a Sanofi Company
- Target Recruit Count
- 840
- Registration Number
- NCT06284915
- Locations
- 🇨🇿
Investigational Site Number : 2030002, Ceske Budejovice, Czechia
🇵🇱Investigational Site Number : 6160001, Bydgoszcz, Kujawsko-pomorskie, Poland
🇷🇴Investigational Site Number : 6420001, Bucuresti, Romania
Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents
- Conditions
- Meningococcal ImmunisationHealthy Volunteers
- Interventions
- Biological: Pentavalent Meningococcal ABCYW vaccineBiological: MenABCYW conjugate vaccineBiological: Placebo
- First Posted Date
- 2023-11-13
- Last Posted Date
- 2025-01-13
- Lead Sponsor
- Sanofi Pasteur, a Sanofi Company
- Target Recruit Count
- 1220
- Registration Number
- NCT06128733
- Locations
- 🇺🇸
Accel Research Site - Birmingham Clinical Research Unit- Site Number : 8400080, Birmingham, Alabama, United States
🇺🇸Alliance for Multispecialty Research- Phoenix- Site Number : 8400056, Tempe, Arizona, United States
🇺🇸Hope Clinical Research, LLC- Site Number : 8400001, Canoga Park, California, United States
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
- Conditions
- Meningococcal ImmunisationHealthy Volunteers
- Interventions
- First Posted Date
- 2023-07-03
- Last Posted Date
- 2024-05-30
- Lead Sponsor
- Sanofi Pasteur, a Sanofi Company
- Target Recruit Count
- 180
- Registration Number
- NCT05929651
- Locations
- 🇦🇷
Investigational Site Number : 0320002, Buenos Aires, Ciudad De Buenos Aires, Argentina
🇦🇷Investigational Site Number : 0320001, Ciudad Autonoma Buenos Aires, Argentina
A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months
- Conditions
- Respiratory Syncytial VirusHuman Metapneumovirus
- Interventions
- First Posted Date
- 2023-02-24
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- ModernaTX, Inc.
- Target Recruit Count
- 310
- Registration Number
- NCT05743881
- Locations
- 🇺🇸
Los Angeles Children's Hospital, Los Angeles, California, United States
🇺🇸Palmetto Pediatrics, PA, North Charleston, South Carolina, United States
🇿🇦Family Centre for Research with Ubuntu (FAMCRU)- Tygerberg, Cape Town, Western Cape, South Africa
Meningococcal Serogroup ACYWX Conjugate Vaccine in Comparison With MenACWY-TT Conjugate Vaccine
- First Posted Date
- 2021-10-26
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- Emory University
- Target Recruit Count
- 1325
- Registration Number
- NCT05093829
- Locations
- 🇲🇱
Centre pour le Developpement des Vaccins du Mali, Bamako, Mali
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Adenovirus Serotype 26 Based Respiratory Syncytial Virus Pre-fusion (Ad26.RSV.Pre-F) Vaccine in RSV-Seronegative Toddlers 12 to 24 Months of Age
- Conditions
- Respiratory Syncytial Virus
- Interventions
- First Posted Date
- 2018-07-31
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Janssen Vaccines & Prevention B.V.
- Target Recruit Count
- 38
- Registration Number
- NCT03606512
- Locations
- 🇧🇷
Irmandade Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Brazil
🇧🇷Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da PUCRS, Porto Alegre, Brazil
🇫🇮Turun rokotetutkimusklinikka, Turku, Finland
Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe
- Conditions
- Meningococcal Infections
- Interventions
- Biological: MenACYW conjugate vaccineBiological: Meningococcal group A, C, W-135, and Y conjugate vaccineBiological: DTaP-IPV-HB-Hib vaccineBiological: Pneumococcal vaccine (10-valent)Biological: Pneumococcal vaccine (13-valent)Biological: MMR vaccine
- First Posted Date
- 2018-06-06
- Last Posted Date
- 2025-03-03
- Lead Sponsor
- Sanofi Pasteur, a Sanofi Company
- Target Recruit Count
- 1660
- Registration Number
- NCT03547271
- Locations
- 🇨🇿
Investigational Site Number : 2031006, Chlumec Nad Cidlinou, Czechia
🇨🇿Investigational Site Number : 2031013, Domazlice, Czechia
🇨🇿Investigational Site Number : 2031010, Jindrichuv Hradec, Czechia
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US
- Conditions
- Healthy Volunteers (Meningococcal Infection)
- Interventions
- Biological: MenACYW-135 conjugate vaccineBiological: DTaP-IPV//Hib vaccineBiological: Pneumococcal 13-valent conjugate vaccineBiological: Measles, mumps, rubella (MMR) vaccine
- First Posted Date
- 2018-05-25
- Last Posted Date
- 2024-10-14
- Lead Sponsor
- Sanofi Pasteur, a Sanofi Company
- Target Recruit Count
- 2627
- Registration Number
- NCT03537508
- Locations
- 🇺🇸
Helios Clinical Research Site Number : 8400109, Houston, Texas, United States
🇺🇸Wee Care Pediatrics Syracuse Site Number : 8400024, Syracuse, Utah, United States
🇺🇸Birmingham Pediatric Associates Site Number : 8400026, Birmingham, Alabama, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.